To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the treatment of hairy cell leukemia (HCL), experiments were carried out to specify the cytotoxic events taking place following this type of therapy. Although an increased natural killer (NK) activity was demonstrable after alpha-IFN treatment, evidence has been provided that hairy cells were not specifically lysed either by fresh autologous/allogenic NK lymphocytes or by lymphokine activated killer (LAK) cells. This property could not be induced in vitro by alpha-IFN or by interleukin-2 (IL-2). Our data favour the hypothesis that the increase of NK cell activity observed following alpha-IFN therapy has not a direct antineoplastic effect but is lik...
Experiments herein reported were designed to clarify the degree of sensitivity of hairy cells to lys...
This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treat...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hai...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukem...
Natural killer (NK) cell activity is severely impaired in untreated patients with hairy cell leukemi...
To investigate the possible direct effects of interferon-α (IFN-α) in hairy-cell leukaemia, IFN-α re...
The "in vitro" effect of IFN-alpha on the phenotypic profile of atypical cells from 5 hairy cell leu...
Although hairy cell leukemia is uniquely sensitive to interferon- (IFN-), the biologic basis for th...
Natural killer (NK) activity against K-562 tumor cells was evaluated in peripheral blood leukocytes ...
Experiments herein reported were designed to clarify the degree of sensitivity of hairy cells to lys...
Experiments herein reported were designed to clarify the degree of sensitivity of hairy cells to lys...
This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treat...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hai...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukem...
Natural killer (NK) cell activity is severely impaired in untreated patients with hairy cell leukemi...
To investigate the possible direct effects of interferon-α (IFN-α) in hairy-cell leukaemia, IFN-α re...
The "in vitro" effect of IFN-alpha on the phenotypic profile of atypical cells from 5 hairy cell leu...
Although hairy cell leukemia is uniquely sensitive to interferon- (IFN-), the biologic basis for th...
Natural killer (NK) activity against K-562 tumor cells was evaluated in peripheral blood leukocytes ...
Experiments herein reported were designed to clarify the degree of sensitivity of hairy cells to lys...
Experiments herein reported were designed to clarify the degree of sensitivity of hairy cells to lys...
This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treat...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...